<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116390">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01587963</url>
  </required_header>
  <id_info>
    <org_study_id>0220100048</org_study_id>
    <nct_id>NCT01587963</nct_id>
  </id_info>
  <brief_title>High Dose Vitamin C in the Critically Ill Patient</brief_title>
  <acronym>VitC</acronym>
  <official_title>The Efficacy of High Dose Vitamin C in the Critically Ill Patient Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been shown that the stress that occurs during trauma, infection and/or shock depletes
      many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to
      further complications. The purpose of this study is to determine the effectiveness of high
      doses of Vitamin C in critically ill patients.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI's additional responsibilities and time commitments prevent him from completing this
    clinical trial so he decided to close the study prematurely
  </why_stopped>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of high dose vitamin C therapy in shock patients</measure>
    <time_frame>30 days</time_frame>
    <description>Given the grim prognosis of septic and hypovolemic shock, we aim to study the efficacy on an alternative treatment modality by implementing high dose vitamin C therapy in our patient population. Through previous investigations, especially research in the burn patient population, we expect that high dose vitamin C therapy will be beneficial to patients with hypovolemic or septic shock.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Shock</condition>
  <arm_group>
    <arm_group_label>Ascorbic Acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ascorbic Acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ringers Lactate or Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ringers Lactate or Normal Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ascorbic Acid</intervention_name>
    <description>66mg/kg/hour of peripheral intravenous Vitamin C infusion for 24 hour duration, maximum total of 200 grams</description>
    <arm_group_label>Ascorbic Acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ringers Lactate or Normal Saline</intervention_name>
    <description>Fluid resuscitation will be given with NS or LR to achieve a same mean urine output of 0.5cc/kg/hour.</description>
    <arm_group_label>Ringers Lactate or Normal Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Activation of the Mass Transfusion Protocol following surgery or trauma.

          -  Diagnosis of septic shock. Septic shock will be defined as sepsis induced hypotension
             (i.e. systolic blood pressure &lt;90mmHg or drop of systolic blood pressure &gt;40mmHg in
             the presence of infection) that does not respond to a 2 liter fluid bolus.

        Exclusion Criteria:

          -  Age less than 18 years.

          -  Pregnant women.

          -  Creatinine of greater than 2.2 g/dl at time of enrollment, history of chronic kidney
             or end stage renal disease, rise in creatinine &gt; 1 g/dl within 24 hours prior to
             enrollment.

          -  Brain death diagnosed within 4 hours of presentation to the trauma bay or intensive
             care unit

          -  Patients with history of hemolytic blood disease, e.g. glucose-6-phosphate
             dehydrogenase deficiency, Sickle Cell Disease and Thalassemia.

          -  Patients in isolated cardiogenic shock.

          -  History of liver cirrhosis

          -  Transplant patients (liver, kidney, heart)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vicente Gracias, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWJMS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Robert Wood Johnson University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <lastchanged_date>May 20, 2015</lastchanged_date>
  <firstreceived_date>April 26, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypovolemic or septic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
